Lombard Odier Asset Management (Switzerland)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $715K | Buy |
+3,899
| New | +$718K | 0.03% | 334 |
|
|
2025
Q4 | – | Sell |
-17,264
| Closed | -$2.42M | – | 279 |
|
|
2025
Q3 | $2.42M | Buy |
17,264
+834
| +5% | +$113K | 0.11% | 163 |
|
|
2025
Q2 | $2.06M | Sell |
16,430
-4,622
| -22% | -$576K | 0.1% | 168 |
|
|
2025
Q1 | $2.88M | Buy |
+21,052
| New | +$3.01M | 0.17% | 131 |
|
|
2024
Q2 | – | Sell |
-3,595
| Closed | -$775K | – | 222 |
|
|
2024
Q1 | $775K | Buy |
+3,595
| New | +$842K | 0.05% | 255 |
|
|
2023
Q2 | – | Sell |
-2,686
| Closed | -$747K | – | 173 |
|
|
2023
Q1 | $747K | Buy |
2,686
+123
| +5% | +$34K | 0.07% | 225 |
|
|
2022
Q4 | $710K | Buy |
2,563
+991
| +63% | +$280K | 0.06% | 221 |
|
|
2022
Q3 | $420K | Sell |
1,572
-2,475
| -61% | -$526K | 0.04% | 206 |
|
|
2022
Q2 | $825K | Buy |
+4,047
| New | +$827K | 0.07% | 170 |
|
|
2022
Q1 | – | Sell |
-102,484
| Closed | -$24.6M | – | 192 |
|
|
2021
Q4 | $24.6M | Buy |
102,484
+18,138
| +22% | +$4.66M | 1.57% | 25 |
|
|
2021
Q3 | $23.8M | Buy |
84,346
+7,217
| +9% | +$2.37M | 1.48% | 23 |
|
|
2021
Q2 | $26.7M | Buy |
77,129
+75,362
| +4,265% | +$22.8M | 1.35% | 18 |
|
|
2021
Q1 | $494K | Buy |
+1,767
| New | +$477K | 0.03% | 245 |
|
|
2020
Q4 | – | Sell |
-7,175
| Closed | -$2.04M | – | 149 |
|
|
2020
Q3 | $2.04M | Buy |
+7,175
| New | +$2M | 0.21% | 77 |
|
|
2020
Q2 | – | Sell |
-2,858
| Closed | -$904K | – | 170 |
|
|
2020
Q1 | $904K | Buy |
2,858
+1,640
| +135% | +$498K | 0.12% | 130 |
|
|
2019
Q4 | $361K | Sell |
1,218
-496
| -29% | -$138K | 0.03% | 276 |
|
|
2019
Q3 | $399K | Sell |
1,714
-2,645
| -61% | -$616K | 0.04% | 262 |
|
|
2019
Q2 | $1.02M | Sell |
4,359
-2,968
| -41% | -$685K | 0.1% | 163 |
|
|
2019
Q1 | $1.73M | Buy |
7,327
+3,663
| +100% | +$1.15M | 0.18% | 101 |
|
|
2018
Q4 | $1.1M | Sell |
3,664
-3,914
| -52% | -$1.25M | 0.13% | 135 |
|
|
2018
Q3 | $2.68M | Sell |
7,578
-14,641
| -66% | -$5.04M | 0.27% | 83 |
|
|
2018
Q2 | $6.45M | Sell |
22,219
-766
| -3% | -$215K | 0.68% | 41 |
|
|
2018
Q1 | $6.29M | Buy |
22,985
+21,883
| +1,986% | +$6.79M | 0.65% | 41 |
|
|
2017
Q4 | $351K | Hold |
1,102
| – | – | 0.03% | 262 |
|
|
2017
Q3 | $345K | Hold |
1,102
| – | – | 0.03% | 271 |
|
|
2017
Q2 | $299K | Hold |
1,102
| – | – | 0.03% | 299 |
|
|
2017
Q1 | $301K | Buy |
+1,102
| New | +$312K | 0.03% | 304 |
|
|
2016
Q3 | – | Sell |
-1,102
| Closed | -$266K | – | 123 |
|
|
2016
Q2 | $266K | Sell |
1,102
-212
| -16% | -$55.9K | 0.04% | 244 |
|
|
2016
Q1 | $342K | Hold |
1,314
| – | – | 0.04% | 203 |
|
|
2015
Q4 | $407K | Hold |
1,314
| – | – | 0.05% | 194 |
|
|
2015
Q3 | $385K | Sell |
1,314
-1,250
| -49% | -$413K | 0.04% | 197 |
|
|
2015
Q2 | $1.04M | Sell |
2,564
-564
| -18% | -$226K | 0.08% | 128 |
|
|
2015
Q1 | $1.33M | Sell |
3,128
-9,867
| -76% | -$3.89M | 0.15% | 100 |
|
|
2014
Q4 | $4.43M | Sell |
12,995
-64,717
| -83% | -$20.9M | 0.48% | 39 |
|
|
2014
Q3 | $25.8M | Buy |
77,712
+75,595
| +3,571% | +$24.9M | 0.66% | 29 |
|
|
2014
Q2 | $665K | Buy |
+2,117
| New | +$637K | 0.07% | 177 |
|
Other funds holding BIIB
VCM
VPM
Lombard Odier Asset Management (Switzerland)'s BIIB Position: Q1 2026 in Review
Lombard Odier Asset Management (Switzerland) opened a new position in Biogen (BIIB) in Q1 2026: 3,899 shares worth $715K. The stake represents 0.03% of the portfolio and ranks #334 among its holdings. This is a return to the name: Lombard Odier Asset Management (Switzerland) previously reported a position in BIIB as recently as Q3 2025.
Lombard Odier Asset Management (Switzerland) first reported a position in BIIB in Q2 2014 and has held it in 36 quarters since. The position peaked at $26.7M in Q2 2021. 1,005 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Lombard Odier Asset Management (Switzerland) held 3,899 shares of Biogen worth $715K as of Q1 2026.
- Biogen was a new Lombard Odier Asset Management (Switzerland) position in Q1 2026.
- Biogen made up 0.03% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #334 holding.
- Lombard Odier Asset Management (Switzerland) first reported a position in Biogen in Q2 2014 and has held it in 36 quarters since.
- Lombard Odier Asset Management (Switzerland)'s Biogen position peaked at $26.7M in Q2 2021.
- 1,005 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.